Searchable abstracts of presentations at key conferences in endocrinology

ea0056gp66 | Cardiovascular | ECE2018

Evaluation of irisin levels in chronic heart failure with preserved or reduced ejection fraction

Mancini Antonio , Silvestrini Andrea , Bruno Carmine , Vergani Edoardo , Brunetti Alessandro , Favuzzi Angela Maria Rita , Guidi Francesco , Meucci Elisabetta , Mordente Alvaro

Background: The recently discovered myokin Irisin, a peptide originated by a proteolytic cleavage of the transmembrane protein fibronectin type III domain containing 5 (FNDC5) whose expression is induced by exercise and/or by increasing peroxisome proliferator-activated receptor (PPAR)-γ co-activator 1α (PGC-1α), has been considered a prognostic factor in Chronic Ischemic Cardiomyopathy and Acute Heart Failure. Nevertheless, no data are available on Irisin level...

ea0070aep15 | Adrenal and Cardiovascular Endocrinology | ECE2020

Multiple hormonal deficiency in heart failure with preserved ejection fraction: Prevalence and role in modulation of antioxidant levels and myocardial dysfunction indexes

Bruno Carmine , Vergani Edoardo , Calarco Rodolfo , Anna Nicolazzi Maria , Maria Rita Favuzzi Angela , d’Abate Claudia , Silvestrini Andrea , Meucci Elisabetta , Mordente Alvaro , Mancini Antonio

In heart failure with reduced ejection fraction, catabolic mechanisms have a strong negative impact on mortality and morbidity. The relationship between anabolic hormonal deficiency and heart failure with preserved ejection fraction (HFpEF) has still been poorly investigated. On the other hand, oxidative stress is recognized as a player in the pathogenesis of HFpEF. Therefore, we performed a cohort study in HFpEF in order to: 1) define the multi-hormonal deficiency prevalence ...